Company Filing History:
Years Active: 2000
Title: Yvonne Maldonado: Innovator in Neonatal Infection Diagnosis
Introduction
Yvonne Maldonado is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of neonatal care. Her innovative work focuses on developing rapid assays for detecting infections in vulnerable populations, such as neonates and immunocompromised patients.
Latest Patents
Maldonado holds a patent for a "Rapid assay for infection in neonates." This assay is designed to diagnose infections in immunodeficient patients, allowing for timely treatment and potentially avoiding unnecessary confinement to intensive care units for uninfected patients. The method is particularly effective for diagnosing sepsis by detecting bacterial, viral, or fungal colonization in the bloodstream, cerebrospinal fluid, or urinary tract. The assay utilizes flow cytometry or laser scanning microscopy to measure polymorphonuclear leukocyte (PMN, neutrophil) CD11b levels in low volume whole blood samples.
Career Highlights
Maldonado is affiliated with Leland Stanford Junior University, where she continues her research and development efforts. Her work has the potential to significantly improve patient outcomes in neonatal care and beyond.
Collaborations
Maldonado collaborates with esteemed colleagues, including Erica E. Weirich and Ronald L. Rabin, to advance her research and innovations in the field.
Conclusion
Yvonne Maldonado's contributions to medical diagnostics, particularly in neonatal infection detection, highlight her role as an influential inventor. Her patented rapid assay represents a significant advancement in the ability to diagnose infections quickly and accurately, ultimately improving care for vulnerable patients.